Creative Biolabs is helping researchers overcome challenges of gene therapy research by providing analytical testing ...
Partnership accelerates AGC Biologics' leadership in the AAV market, applying its BravoAAV™ platform to complex gene therapies for inherited blindness On the heels of AAVantgarde closing a Series B ...
Forbes contributors publish independent expert analyses and insights. William A. Haseltine, Ph.D., covers genomics and regenerative medicine One of the more exciting opportunities in medical ...
Boehringer Ingelheim is discarding an inhaled gene therapy designed to treat cystic fibrosis (CF) after terminating a phase 1/2 trial. | Boehringer Ingelheim is discarding an inhaled gene therapy ...
Kristofer Mussar, PhD, is COO of VectorBuilder and MD of VectorBuilder GmbH, leading global operations and innovation in gene delivery. What if business leaders approached strategy the way scientists ...
CHICAGO--(BUSINESS WIRE)--VectorBuilder, a global leader in gene delivery solutions, is excited to announce that it’s received the BioIndustrial Innovation of the Year award by the BioTech ...
VectorBuilder pioneers cutting-edge innovation for AAV gene delivery, with a one-stop solution supporting programs from research to early discovery to clinical development. Its proprietary technology ...
Pointing to a few empty chairs in a conference room, moderator David T. Curiel joked that a symposium on emerging nonviral vectors was a "failure" compared to other packed talks at the American ...
Therefore, MNDU3 was chosen because it is a strong, ubiquitous promoter–enhancer that drives consistent gene expression across different cell lineages. 8,9 In 2009, in a study involving a small number ...
Creative Biolabs’ advanced viral vector analysis platform is helping researchers and biopharma companies overcome critical bottlenecks in gene therapy development. By delivering accurate, reliable, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results